verified SJR 0,565 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Taylor and Francis Ltd.

workspace_premium Q2 — Pharmacology lock_open Open Access

Journal of Biopharmaceutical Statistics

Journal of Biopharmaceutical Statistics is a journal indexed in SJR in Pharmacology and Statistics and Probability with an H index of 58. It has an SJR impact factor of 0,565 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,565.

ISSN: 1054-3406

Publisher: Taylor and Francis Ltd.

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,565 Q2

H-index 58

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,565

H-index

Docs (year)

143

Docs 3y

201

Total refs

3965

Cites 3y

242

Citable 3y

183

Cites/Doc 2y

1.36

Ref/Doc

27.73

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

An application of methods for clustered binary responses to a cardiovascular study with small sample size

Where is Health-Related Quality-of-Life Assessment in Oncology Clinical Study Heading?

COMPLEMENTARY NONPARAMETRIC ANALYSIS OF COVARIANCE FOR LOGISTIC REGRESSION IN A RANDOMIZED CLINICAL TRIAL SETTING

COMPARISON OF BRACKETING AND MATRIXING DESIGNS FOR A TWO-YEAR STABILITY STUDY

COMMENTS ON NEDELMAN AND JIA'S EXTENSION OF SATTERTHWAITE'S APPROXIMATION APPLIED TO PHARMACOKINETICS

COMBINING SUMMARIES OF BINARY OUTCOMES WITH THOSE OF CONTINUOUS OUTCOMES IN A META-ANALYSIS

CENTER-WEIGHTING ISSUES IN MULTICENTER CLINICAL TRIALS

CARRY-OVER EFFECTS IN BIOEQUIVALENCE STUDIES

BIOEQUIVALENCE REVIEW FOR DRUG INTERCHANGEABILITY

ASSESSMENT OF SELECTION BIAS IN ESTIMATES OF RELATIVE BIOAVAILABILITY AND INTRASUBJECT VARIABILITY FROM BIOEQUIVALENCE EVALUATIONS

Assessing the Agreement Between Two Quantitative Assays with Repeated Measurements

APPLICATION OF GENERALIZED ESTIMATING EQUATIONS TO A DENTAL RANDOMIZED CLINICAL TRIAL

SHOW MORE ARTICLES

ANALYZING COUNTS, DURATIONS, AND RECURRENCES IN CLINICAL TRIALS

A Generalized Additive Model For Microarray Gene Expression Data Analysis

An Adaptive Group Sequential Phase II Design to Compare Treatments for Survival Endpoints in Rare Patient Entities

ADJUSTING DISSOLUTION SPECIFICATIONS FOR THE VARIABILITY INDUCED BY STORAGE CONDITIONS

A TWO-STAGE DOSE SELECTION STRATEGY IN PHASE I TRIALS WITH WIDE DOSE RANGES

A ROBUST SUMMARIZE-REGRESS PROCEDURE FOR TISSUE-SPECIFIC PHARMACOKINETICS

A REMARK ON SMALL-SAMPLE PROPERTIES OF LOGISTIC REGRESSION IN THREE-POINT DESIGNS

A Quality-Adjusted Survival (Q-TWiST) Model for Evaluating Treatments for Advanced Stage Cancer

A MODIFIED LARGE SAMPLE APPROACH IN THE ASSESSMENT OF POPULATION BIOEQUIVALENCE

A METHOD FOR ESTIMATING AND TESTING AREA UNDER THE CURVE IN SERIAL SACRIFICE, BATCH, AND COMPLETE DATA DESIGNS

A MEASURE OF ASSOCIATION BETWEEN TWO SETS OF MULTIVARIATE RESPONSES

A Knowledge-Based Clustering Algorithm Driven by Gene Ontology

FAQs

Journal of Biopharmaceutical Statistics has an SJR of 0,565 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Biopharmaceutical Statistics is 30%.

Journal of Biopharmaceutical Statistics

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Biopharmaceutical Statistics?

What is the APC / publication cost?

What is the acceptance rate?